Results 91 to 100 of about 314,408 (190)

Chronic pancreatitis and pancreatic cancer; the clinical aspects and treatment of pancreatic exocrine insufficiency [PDF]

open access: yes, 2013
In exocrine pancreatic insufficiency, the pancreas is unable to deliver a sufficient quantity of pancreatic enzymes to the small intestine to digest food.
Sikkens, E.C.M. (Edmée)
core   +1 more source

Long-term quality of life and exocrine and endocrine insufficiency after pancreatic surgery: a multicenter, cross-sectional study

open access: yes, 2021
Background: Data regarding long-term quality of life and exocrine and endocrine insufficiency after pancreatic surgery for premalignant and benign (non-pancreatitis) disease are lacking.
for the Dutch Pancreatic Cancer Group
core  

Exocrine pancreatic insufficiency in celiac sprue

open access: yesGastroenterology, 1981
there were no other conditions favoring the development of a colitis or granulomas. Finally, it is simply not clear to us why a case of uncomplicated small intestinal lymphoma should have associated colonic abnormalities, and we have seen many cases without these effects.
N, Ansaldi, G, Oderda
openaire   +2 more sources

Pancreatic Atrophy: A Narrative Review and Surgical Interpretation

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1419-1427, September 2026.
Pancreatic parenchymal atrophy pattern and intraoperative margin assessment guide surgical strategy. ABSTRACT Despite recent advances in multimodal management, pancreatic ductal adenocarcinoma remains a fatal malignancy. Early detection of indirect findings of pancreatic ductal adenocarcinoma is essential to improve treatment outcomes, drawing ...
Rika Fujino   +4 more
wiley   +1 more source

COMPARISON OF FECAL ELASTASE 1 FOR EXOCRINE PANCREATIC INSUFFICIENCY EVALUATION BETWEEN EX-ALCOHOLICS AND CHRONIC PANCREATITIS PATIENTS

open access: yesArquivos de Gastroenterologia, 2014
Context Fecal elastase is a noninvasive test for pancreatic insufficiency diagnosis. Objectives Evaluate the usefulness of fecal elastase 1 for the indication of exocrine pancreatic insufficiency among former alcohol addicts and patients with chronic ...
Rejane MATTAR   +5 more
doaj   +1 more source

Pregnancy‐related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3202-3213, September 2026.
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas   +16 more
wiley   +1 more source

GASTROINTESTINAL INVOLVEMENT IN SJÖGREN’S DISEASE

open access: yesRheumatology Quarterly
Sjögren’s syndrome (SjS) is a chronic autoimmune disorder characterized by lymphocytic infiltration of the exocrine glands, which can also affect the gastrointestinal (GI) tract, hepatobiliary system, and pancreatic exocrine tissues.
Fuat Albayram   +3 more
doaj   +1 more source

Prevalence of Exocrine Pancreatic Insufficiency in Patients with Irritable Bowel Syndrome Predominant Diarrhea [PDF]

open access: yesAl-Azhar International Medical Journal
Background: With a global prevalence of 7.6-10.8% according to Rome IV criteria, irritable bowel syndrome (IBS) is among the most common illnesses seen in clinical practice.
Atef Ebraheim   +3 more
doaj   +1 more source

Pancreatic enzyme therapy for pancreatic exocrine insufficiency

open access: yesCurrent Gastroenterology Reports, 2007
Pancreatic exocrine insufficiency with steatorrhea is a major consequence of pancreatic diseases (eg, chronic pancreatitis, cystic fibrosis, severe acute necrotizing pancreatitis, pancreatic cancer), extrapancreatic diseases such as celiac disease and Crohn's disease, and gastrointestinal and pancreatic surgical resection. Recognition of this entity is
openaire   +4 more sources

A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3257-3264, September 2026.
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are widely used in patients with cystic fibrosis and significantly improve respiratory function and quality of life. However, their effectiveness may be limited by liver damage, which sometimes leads to treatment discontinuation, and the mechanisms underlying this remain poorly ...
Clara Laffitte Redondo   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy